Francois Ghiringhelli

72PUBLICATIONS
268CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jun 22, 2026
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.

|Jun 20, 2026
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.

|Jun 02, 2026
The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.

|May 13, 2026
Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity.

|May 08, 2026
Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts.

|Mar 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer.

John H Strickler, Judith Raimbourg, Jonathan E Cohen

Pageof 12

Frequent Collaborators

17 joint publications

Caroline Truntzer

10 joint publications

Cédric Rébé

10 joint publications

Romain Boidot

6 joint publications

Nicolas Roussot